cells that share some properties in common with NK cells. NKT cells are CD1d restricted, lipid antigen reactive cells that express a limited array of T-cell receptors (TCRs). 12 The most widely studied NKT cells in mice and humans are the invariant NKT cells defined by the expression of an invariant TCRα chain (Vα14-Jα18 in mice and Vα24-Jα18 in humans) paired with particular TCR-Vβ chains (Vβ2, 7 or 8 in mice and Vβ11 in humans). NKT cells display cytotoxic activity against tumors, 13, 14 including perforin-dependent cytotoxicity against hematopoietic malignancies. 15 Mouse NKT cells kill spontaneous tumors in vitro in a perforin-dependent manner. 16 On stimulation by glycolipid antigens and interleukin (IL)-12, NKT cells secrete large amounts of cytokines, including interferon (IFN)-γ and IL-4, 17 and initiate bystander activation of other immune cells including NK cells, B and T cells. [18] [19] [20] In ApoE −/− mice, NKT cell activation elevates proinflammatory cytokine levels, IFN-γ, tumor necrosis factor-α, and IL-4 and augments atherosclerotic development. 21 Conversely, NKT cell deficiency generated in knockout or chimeric mice with depletion of CD1d or Jα18 TCR genes attenuates atherosclerosis, [22] [23] [24] [25] whereas cell transfer from Vα14Jα18 TCR transgenic donor into lymphocyte-deficient Rag1 −/− LDLR −/− mice promotes atherosclerosis. 26 NKT cells exist as multiple subsets. CD4 + and CD4 − CD8 − (double negative) NKT cells are the major subsets in mice. 27 Recently, we demonstrated that CD4 + but not double-negative-NKT cells contribute to the development of atherosclerotic lesions. 28 This differential ability of the 2 subtypes to affect developing lesions seemed to be because of their differential expression of Ly49 inhibitory receptors, which are expressed to a much greater extent on double-negative-NKT cells preventing proatherogenic actions. 28 Despite numerous studies implicating NKT cells in atherosclerosis, [22] [23] [24] [25] [26] the mechanisms by which these cells augment atherosclerosis are not known. Possible mechanisms include bystander lymphocyte activation, [18] [19] [20] inflammatory cytokine secretion, and induction of apoptosis via cytotoxic mechanisms, 29, 30 or combination of these actions. Efferocytosis, the process for clearing apoptotic cells, is defective in atherosclerotic lesions and this leads to postapoptotic necrosis and development of necrotic cores. 31 Necrotic cells in turn promote inflammation by releasing HMGB1 (highmobility group protein B1) and activating inflammasomes. 32 In the present study, we examined whether NKT cells require bystander lymphocytes, cytokines, or cytotoxins to exert their proatherogenic effects. We demonstrate that the proatherogenic effects of CD4 + NKT cells occur independently of other lymphocytes or the cytokines IFN-γ, IL-4, and IL-21 but are dependent on perforin and granzyme B-mediated cytotoxicity.
Methods

Experiment Design and Animal Ethics
Male atherogenic mice were fed a high-fat diet (HFD) consisting of 21% butter fat and 0.15% cholesterol (specialty feeds) for 8 weeks, commencing at 6 weeks of age. At the end of the study mice were killed with an overdose of pentobarbitone (120 mg/kg IP), blood collected by cardiac puncture, and aortic sinus collected for histology and immunohistochemistry.
In adoptive transfer experiments, NKT cells (3×10 5 ) were purified by flow cytometric sorting and intravenously injected via the tail vein into 6-week-old B-and T-cell-deficient ApoE −/− Rag2 −/− and lymphocyte-deficient ApoE −/− Rag2 −/− γc −/− mice; CD4 + NKT cells from wildtype (WT), IFN-γ, IL-4, IL-21, perforin, and granzyme B-deficient mice were intravenously injected into 6-week-old NKT cell-deficient ApoE −/− Jα18 −/− mice. Controls received equivalent intravenous injections of PBS.
All animal experiments were approved by AMREP (Alfred Medical Research and Education Precinct) Animal Ethics Committee.
For detailed Materials and Methods, see the Online Data Supplement.
Results
NKT Cells Can Promote Atherosclerosis Independently of T, B, and NK Cells
NKT cells may exert their effects by activating bystander CD4 + T cells, 33 CD8 + T cells, 20 and B cells 34 that have been implicated in atherosclerotic development. 3, 7, 35 To determine whether these cells are required for the proatherogenic action of NKT cells, we adoptively transferred 3×10 5 liver NKT cells into T-and B-cell-deficient ApoE −/− Rag2 −/− mice followed by 8 weeks of a HFD. NKT cell transfer augmented atherosclerotic development by nearly doubling the size of atherosclerotic lesions assessed by intimal lesion area (P<0.05; Figure 1A ). Accumulation of macrophages (1.5-fold) and lipid (0.8-fold) was increased (P<0.05; Figure 1A ), indicating that neither T cells nor B cells were necessary for NKT cells to augment the development of atherosclerosis.
Because NKT cells can also activate NK cells, we next investigated whether proatherogenic effects of NKT cells are dependent on NK cell activation. 18 Adoptive transfer of NKT cells into lymphocyte-deficient ApoE −/− Rag2 −/− γc −/− mice also augmented development of atherosclerosis by increasing intimal lesion area and macrophage and lipid accumulation (P<0.05; Figure 1B ). NKT cell transfer into the ApoE −/− Rag2 −/− or ApoE −/− Rag2 −/− γc −/− mice did not affect very-low-density lipoprotein /low-density lipoprotein-lipid levels. A slight, but not statistically significant decreasing trend was observed in all cholesterols measured (P>0.05) apart from a significantly reduced HDL in ApoE −/− Rag2 −/− γc −/− mice (P<0.05); however, the HDL reduction in ApoE −/− Rag2 −/− mice did not reach statistically significance (P>0.05; Online Table I ).
CD4 + NKT Cells Can Promote Atherosclerosis Independently of IFN-γ, IL-4, and IL-21 Production
NKT cells can secrete proinflammatory cytokines such as IFN-γ, 36 which augment atherosclerotic development. 37 Because we previously demonstrated that CD4 + , and not double-negative NKT, cells augment atherosclerosis, 28 we focused solely on CD4 + NKT cells. To determine whether CD4 + NKT cell-derived IFN-γ is required for their proatherogenic action, we transferred CD4 + NKT cells isolated from WT and
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TCRα T-cell receptor α chain WT wild-type IFN-γ −/− mice into NKT cell-deficient ApoE −/− Jα18 −/− mice followed by feeding a HFD for 8 weeks. Similar to the effects of WT CD4 + NKT cell transfer to ApoE −/− Jα18 −/− mice, transfer IFN-γ-deficient CD4 + NKT cells increased lesion size (assessed by total lesion area) to nearly double and also macrophage and lipid accumulation (P<0.05; Figure 2 ). These data indicate that IFN-γ is not required for CD4 + NKT cells to exert their proatherogenic effects. As IL-4 has also been shown to be proatherogenic 5 and NKT cells secrete IL-4, 38 we next assessed the role of IL-4 derived from NKT cells for atherogenesis. Adoptive transfer of CD4 + NKT cells deficient in IL-4 also augmented atherosclerosis, doubling the size of lesions and also increasing macrophage and lipid accumulation (P<0.05; Figure 2 ). We next assessed the importance of IL-21 secreted by NKT cells; IL-21 augments cytokine secretion by NKT cells 39 and is expressed in atherosclerotic lesions. 40 IL-21-deficient CD4 + NKT cells also augmented atherosclerotic development, by ≈60% increase the size of atherosclerotic lesions (P<0.05; Figure 2 ). Plasma lipid levels were similar in the different groups of mice except for a small 12% increase in the group that received CD4 + NKT cells deficient in IFN-γ (Online Table II ).
CD4 + NKT Cells Require Perforin and Granzyme B for Atherosclerotic Development
An increase in the frequency of apoptotic cells in developing lesions is associated with increases in atherosclerotic lesion size. 41, 42 Because perforin and granzyme B induce apoptosis 43 and these are major cytotoxins by which NKT cells induce cell death, 29 we assessed the effects of perforin and granzyme B deficiency in CD4 + NKT cells on atherosclerotic development. Wild-type CD4 + NKT cells increased lesion size by ≈70% (P<0.05; Figure 3 ) as well as increasing both macrophage and lipid accumulation (P<0.05), whereas transfer of perforin or granzyme B-deficient CD4 + NKT cells did not significantly increase lesion size (P>0.05; Figure 3 ). Similarly, transfer of perforin and granzyme B-deficient NKT cells did not significantly increase macrophage accumulation (P>0.05; Figure 3 ) and apparent increases in lipid accumulation were also not statistically significant (P>0.05; Figure 3 ); Together, these studies indicate that perforin and granzyme B are required for the proatherogenic action of CD4 + NKT cells. Plasma cholesterol levels were slightly elevated (15%) in mice transferred with granzyme B-deficient CD4 + NKT cells (P<0.05), but this did not significantly increase atherosclerosis (Online Table II ).
Adoptive Transfer of Perforin-Deficient CD4 + NKT Cells Results in Smaller Necrotic Cores and Reduced Apoptosis in Developing Lesions
In atherosclerotic lesions defective clearance of apoptotic cells leads to postapoptotic necrosis and development of larger necrotic cores. 44 To determine whether CD4 + NKT cell-derived perforin contributed to the development of necrotic cores, we compared acellular regions of atherosclerotic lesions from ApoE −/− Jα18 −/− mice receiving either vehicle (control), WT CD4 + NKT cells, or perforin-deficient CD4 + NKT cells. After adoptive transfer of WT CD4 + NKT, the necrotic core defined as percent lesion area occupied by acellular material increased in size compared with control (P<0.05; Figure 4A ). In contrast, necrotic cores within lesions of mice receiving perforin-deficient CD4 + NKT cells were similar to control (P>0.05; Figure 4A ). A similar profile of effects was observed on apoptotic cells defined by terminal deoxynucleotidyl transferase dUTP nick end labeling assay (TUNEL) and active caspase 3 staining within lesions ( Figure 4B and 4C). Besides accumulation of apoptotic cells, defective apoptotic cell clearance by phagocytes (efferocytosis) also contributes to necrotic core generation. 44 Therefore, we investigated efferocytosis by assessing macrophage clearance of apoptotic cells after transfer of WT and perforin-deficient CD4 + NKT cells into ApoE −/− Jα18 −/− mice. Both WT and perforin-deficient NKT cells enhanced macrophage efferocytosis indicating that efferocytosis does not contribute to the action of perforin on necrotic core formation ( Figure 4D ).
CD4 + NKT Cells Stimulate Proinflammatory Mediators
Necrotic cells trigger sterile inflammatory responses by releasing the alarmin HMGB1 45 and activating Nlrp3 inflammasomes, which in turn activate IL-1β and IL-18, 32, 46 proinflammatory mediators, which augment the development of atherosclerosis. 45, [47] [48] [49] We examined whether VCAM-1 (vascular cell adhesion molecule) and MCP-1 (monocyte chemotactic protein) elevated by these proinflammatory mediators 47, 50, 51 were altered in lesions of ApoE −/− Jα18 −/− mice that received CD4 + NKT cells from WT, perforin-deficient, and granzyme B-deficient mice. Eight weeks after feeding a HFD, VCAM-1 expression in lesions of mice that received CD4 + NKT cells deficient in perforin or granzyme B was reduced compared with mice that received CD4 + NKT cells from WT mice (P<0.05; Figure 5A ); similarly, lesion MCP-1 expression was also attenuated (P<0.05; Figure 5B ). Similar increased expression of VCAM-1 and MCP-1 was observed in T-and B-cell-deficient ApoE −/− Rag2 −/− mice and lymphocyte-deficient ApoE −/− Rag2 −/− γc −/− mice that received WT perforin-or granzyme-competent NKT cells (P<0.05; Figure 5D and 5E).
Donor NKT Cells Do Not Express ApoE
To investigate whether donor CD4 + NKT cells express ApoE, we determined the expression of ApoE mRNA in NKT cells and macrophages from WT and ApoE −/− mice. We found that although macrophages from WT mice express ApoE, WT NKT cells from both chow diet and 8-week HFD-fed mice did not ( Figure 6A ), suggesting that NKT cells from ApoEcompetent donor mice do not influence result outcomes by producing ApoE.
Donor NKT Cells Are Found in the Liver and Atherosclerotic Lesions of Recipient Mice
We performed 2 experiments. First, we tracked CD4 + NKT cells after their adoptive transfer from congenic Ly5.1 mice. We identified Ly5.1 + NKT cells identified by flow cytometry 48 hours after transfer, where they comprised ≈20% of liver NKT cells compared with WT mice ( Figure 6B ). Immunofluorescence microscopy performed on aortic sinus of lymphocyte-deficient mice that received Ly5.1 CD4 + NKT cells at the beginning of 8-week HFD showed Ly5.1 NKT cells in close proximity to lesion macrophages ( Figure 6C ). Next, we performed quantitative reverse transcription polymerase chain reaction for expression of NKT cell-specific Vα 14-Jα18 TCRα chain in atherosclerotic lesions from arterial RNAs extracted from Rag double knockout (Rag2 −/− ApoE −/− ) mice that received either PBS or NKT cells compared with ApoE −/− mice. We found that the expression of NKT cell-specific TCRα chain after NKT cell transfer that was ≈40% to 50% of that in ApoE −/− mice, findings supported by representative reverse transcription polymerase chain reaction products are visualized on gel electrophoresis (Online Figure I) . We compared the atherogenicity of liver-derived CD4 + NKT cells with total spleen-derived CD4 + CD25 − T cells, by the transfer of 3×10 5 of these cells to lymphocyte-deficient ApoE −/− mice. We selected CD4 + CD25 − T cells for transfer to exclude the presence of CD25 + regulatory CD4 + T cells that are atheroprotective. 52 Atherosclerosis at the end of 8-week HFD showed a significant doubling in lesion size after transfer of CD4 + NKT cells compared with transfer of CD4 + CD25 − T cells, consistent with a potent atherogenic action of CD4 + NKT cells (Online Figure II) . We found similar expression of perforin and granzyme B in NKT cell-transferred and PBStransferred mice (Online Figure III ).
Discussion
The present study has identified unexpected and novel mechanisms by which NKT cells augment atherosclerosis. The mechanisms did not require activation of bystander B cells, T cells, or NK cells nor the secretion of proinflammatory cytokines IFN-γ, IL-4, and IL-21. Rather, actions of perforin and granzyme B are essential for their proatherogenic effects; perforin and granzyme B-deficient CD4 + NKT cells did not increase lesion size, lesion macrophage accumulation, or lesion lipid accumulation. CD4 + NKT cells producing perforin and granzyme B seem to augment atherosclerosis by inducing apoptosis resulting in augmented postapoptotic necrosis, reflected by increased necrotic core size within lesions. Arterial mRNA expression of perforin and granzyme B was not different in recipients that received CD4 + NKT cells compared with PBS, suggesting that NKT-derived cytotoxins likely mediate their cytotoxicity by polarized secretion at immunologic synapses on target cells. 53 The suggestion is supported by immunofluorescent colocalization of NKT cells with macrophages in atherosclerotic lesions. Expression of the atherosclerosis-promoting molecules, MCP-1 and VCAM-1, 54,55 are consistent with necrotic cells triggering a sterile inflammatory responses by releasing the alarmin HMGB1 and stimulating the secretion of active IL-1β and IL-18 by activating inflammasomes in atherosclerotic lesions. 32, 46, 56 The role of lymphocytes in atherosclerosis was thought to be minor in early reports. 57, 58 It is difficult to interpret these studies as unlike our studies where congenic ApoE −/− and Rag2 −/− mice (and γc −/− mice) were used to generate lymphocyte-deficient mice on the C57BL/6 genetic background, experimental mice in the earlier studies were generated from mice on mixed genetic backgrounds. Furthermore, our recent studies using lymphocyte-deficient mice on C57Bl/6 background 7 and the 2001 report using T-and B-cell-deficient ApoE −/− Rag2 −/− mice on C57Bl/6 genetic background 59 exhibited markedly smaller lesions than WT mice fed a HFD for 8 weeks. Our model of lymphocyte-deficient mice fed a HFD is a sensitive model to demonstrate that conventional B cells and CD8 T cells are proatherogenic 4,7 and we have again used this model in the present study.
NKT cells are potent immune cells because transfers of small numbers (2.5-3×10 5 cells) exert potent effects on tumors, diabetes mellitus, and atherosclerosis. 20, 28, 60, 61 To determine the presence of adoptively transferred NKT cells in recipient mice, we harvested liver lymphocytes 48 hours after transfer of 3×10 5 NKT cells. FACS (fluorescence-activated cell sorting) data showed that the transferred liver NKT cells comprised ≈20% of WT mice (mean±SEM 5.00×10 4 ±0.49 versus 25.86×10 4 ±4.06). Furthermore, we showed that transferred Ly5.1 + NKT cells colocalized with macrophages after 8 weeks on a HFD. Although not investigated here, our previous study 61 suggests that the atherogenic action of NKT cells may be dose dependent.
We assessed the presence of NKT cells in atherosclerotic lesions after transfer of NKT cells from congenic Ly5.1 mice and confirmed our previous report that adoptively transferred NKT cells are home to atherosclerotic lesions. 28 These findings are supported by the demonstration of NKT cells in lesions by reverse transcription polymerase chain reaction after transfer of NKT cells into recipient mice that corresponded to ≈40% of NKT cells in lesions of ApoE −/− mice fed a HFD for 8 weeks. Potency of the CD4 + NKT cell populations is supported by the doubling of atherosclerotic lesion size after transfer of this population compared with transfer of total CD4 + CD25 − T cells free of CD25 + regulatory T cells. Collectively, we conclude that atherogenic CD4 + NKT cells potently promote atherosclerotic development by perforinand granzyme-dependent mechanism in lesions.
Initially, we investigated whether NKT cells could augment atherosclerotic development indirectly, by activating bystander B, T, and NK cells. NKT cells are known to activate B and T cells. B cells express CD1d, suggesting that direct interactions between NKT and B cells can influence B-cell function; conventional B cells promote atherosclerotic development. 7 CD4 + NKT cells have been shown to induce naive and memory B cells to proliferate and secrete IgG1 and IgM. 19, 34 Similarly, NKT cells enhance the proliferation of CD8 + T cells 20 and the proliferation and inflammatory activity of CD4 + T cells. 33 Our findings in ApoE −/− mice deficient in B and T cells indicate that NKT cells can exert proatherogenic effects independently of B and T cells. Although NKT cells can also mediate their effects indirectly by activating NK cells, 18, 62 adoptive transfer of NKT cells into lymphocyte-deficient ApoE −/− Rag2 −/− γc −/− mice also augmented atherosclerosis development by ≈75% that was ≈30% the size of lesions of ApoE −/− mice. Together these studies indicate that NKT cells can augment atherosclerosis independently of other lymphocyte populations, although it is possible that interactions with other lymphocyte populations might further amplify their proatherogenic effects.
Activated CD4 + NKT cells secrete copious amounts of IFN-γ, IL-4, and IL-21. 28, 39 IFN-γ and IL-4 augment development of atherosclerosis, 5, 37 whereas IL-21 augments cytokine secretion by NKT cells 39 and is expressed in atherosclerotic lesions. 40 Our findings indicate that the ability of CD4 + NKT cells to augment atherosclerosis is not dependent on secretion of these cytokines. Although our studies show that NKT cells use perforin and granzyme B to mediate caspase 3-dependent apoptosis in atherosclerotic lesions, other studies report that NKT cells can use multiple mechanisms to mediate cytotoxicity. Thus, NKT cell cytotoxicity directed against tumors used perforin, 15, 16, 30 tumor necrosis factor, or the combination of perforin, tumor necrosis factor, and Fas ligand (CD95L), 63 or TRAIL (TNF-related apoptosisinducing ligand). 64 Our finding that perforin −/− NKT cell transfer is associated with reduced TUNEL-positive apoptotic cells and active caspase 3-positive cells in atherosclerotic lesions is consistent with previous reports that perforin-dependent granzyme B's action initiates caspase 3-dependent apoptosis. 43, 65 Granzyme B and perforin form multimeric complexes with the proteoglycan serglycin in cytotoxic granules and perforin-serglycin complexes mediate cytosolic delivery of macromolecular granzyme B-serglycin at immunologic synapses without producing detectable plasma membrane pores. 66 NKT cell-derived cytotoxins are potent stimulators of apoptosis and in atherosclerotic lesions where removal of apoptotic cells is impaired, 31 this leads to postapoptotic necrosis. Necrotic cells are highly inflammatory, releasing the proatherogenic alarmin HMGB1 45 and metabolic products such as ATP, a potent activator of the NLRP3 (NOD-like receptor family, pyrin domain containing 3) inflammasome, factors that together can augment atherosclerosis. 45, 56 Our findings that augmented atherosclerosis is dependent on CD4 + NKT cells secreting perforin and granzyme B are consistent with such a mechanism. HMGB1 released by necrotic cells likely promotes atherosclerosis by enhancing macrophage recruitment 45 and attenuating apoptotic cell removal by inhibiting efferocytosis, 67 thereby further increasing postapoptotic necrosis. However, efferocytosis is a dynamic process that can be positively regulated by many other factors such as cyclin-dependent kinase inhibitor 2B 68 and milk fat globule-epidermal growth factor 8. 69 NLRP3 inflammasomes are essential for processing the proatherogenic cytokines pro-IL-1β and pro-IL-18 to their active forms. Thus, our findings that MCP-1 and VCAM-1 expression in atherosclerotic lesions is dependent on NKT cell-derived perforin and granzyme B are consistent with HMGB1 and NLRP3 inflammasome-dependent proatherogenic downstream mechanisms.
Our findings that NKT cell-derived perforin and granzyme B lead to accumulation of apoptotic lesions within developing lesions suggest that NKT cells may target macrophages and macrophage-derived foam cells. Macrophages, including macrophage-derived foam cells, express CD1d in atherosclerotic lesions 70 and NKT cells selectively target CD1d-expressing cells for killing primarily via perforin/granzyme B mechanisms. 29, 71 Because vascular smooth muscle cells associated with lesions do not express CD1d, 70 these cells are likely to be spared. This suggestion is consistent with our previous observation that vascular smooth muscle cell numbers associated with lesions are unaffected by NKT cells. 28 We have also recently reported that CD8 T cells 4 and NK cells 72 promote atherosclerosis by perforin-dependent mechanisms. Our present findings suggest that NKT cells may act in concert with these cytotoxic CD8 T cells 4 and NK cells 72 to promote the development of vulnerable, rupture-prone atherosclerotic lesions characterized by abundant apoptosis and large necrotic cores.
VanderLaan et al 26 showed that atherosclerosis augmented by NKT cells adoptively transferred into lymphocyte-deficient LDLR −/− Rag1 −/− mice was limited to aortic sinus without affecting the ascending aortas. Our data also showed that transferred NKT cells into NKT cell-deficient ApoE −/− Jα18 −/− mice increased atherosclerosis at the aortic sinus. Although we did not investigate other arterial sites, it is possible that NKT cell-driven atherosclerosis may differ in different mouse models and in different anatomic areas.
In conclusion, our adoptive transfer studies have shown that neither bystander lymphocytes nor cytokine secretion is essential for NKT cells to exert their proatherogenic effects. Rather, their proatherogenic effects are critically dependent on secretion of the cytotoxins perforin and granzyme B, thereby increasing apoptotic and necrotic cells in lesions which in turn augments inflammation. Targeting downstream NKT cell apoptotic cell mediators may be useful in attenuating atherosclerosis.
